Contact this trialFirst, we need to learn more about you.
Serotonin-Norepinephrine Reuptake Inhibitor
Desvenlafaxine for Depression
Recruiting5 awardsPhase 4
Windsor, Ontario
This trial will examine whether desvenlafaxine is an effective treatment for vascular depression, as well as assessing its safety. The primary efficacy measures will be depressive symptoms and cognition, both measured at baseline and 12 weeks. A sub-group of patients who have experienced a TIA will also be evaluated for efficacy.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.